Tag: adjuvant lung cancer

Overall Survival Improved with Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC

byDaniel Goldshteinand1 others

June 19, 2023

1. The 5-year overall survival had a hazard ratio of 0.49, and this benefit was generally consistent across subgroups (stage, ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Adverse outcomes post-COVID-19 hospitalization among ESRD patients: A retrospective cohort study in 5 California university medical centers
Trends in firearm-related hospitalizations and deaths in New Zealand
Staffing and clinical impacts of private equity acquisition of hospitals

No Result

View All Result